Skip to content

IMMUCELL CORPORATION

NASDAQ: ICCC

Company: ImmuCell Corporation
Ticker: Nasdaq: ICCC
Sector: Healthcare
Investor Contact: Joe Diaz

ImmuCell Corporation

Stock Detail

Nasdaq CM:ICCC
$5.38
04/03/2025 4:03 PMET
Change
$-0.04(-0.74%)
Volume
20,717
Today's Open
$5.42
Previous Close
$5.42
Outstanding
8,982,623
Today's High
$5.68
Today's Low
$5.32
52 Week High
$5.82
52 Week Low
$3.34
Market Cap
$48.327 M
Company Description
ImmuCell Corporation's (Nasdaq: ICCC) purpose is to create scientifically-proven and practical products that improve the health and productivity of dairy and beef cattle. ImmuCell manufactures and markets First Defense®, providing Immediate Immunity™ to newborn dairy and beef calves, and is in the late stages of developing Re-Tain®, a novel treatment for subclinical mastitis in dairy cows without a milk discard requirement that provides an alternative to traditional antibiotics. Visit the company's website for more information, https://immucell.com/.

Videos

ImmuCell (ICCC) Fireside Chat

ImmuCell (ICCC) Fireside Chat

For this presentation we welcome ImmuCell (Nasdaq: ICCC). ImmuCell Corporation's purpose is to create scientifically-proven and practical products that improve the health and productivity of dairy and beef cattle. This fireside chat was recorded during the Lytham...

read more
ImmuCell Corporation (ICCC) Company Webcast

ImmuCell Corporation (ICCC) Company Webcast

ImmuCell Corporation's (Nasdaq: ICCC) purpose is to create scientifically-proven and practical products that improve the health and productivity of dairy and beef cattle. ImmuCell manufactures and markets First Defense®, providing Immediate Immunity™ to newborn dairy...

read more
ImmuCell Corp. (ICCC) Fireside Chat

ImmuCell Corp. (ICCC) Fireside Chat

Today, we welcome ImmuCell Corporation, which trades on the NASDAQ under the ticker, ICCC. We'll be engaging today with Michael Brigham, CEO of ImmuCell and a number of his sales team members in a discussion to give you a sense of the traction and the momentum they're...

read more

News

Arrow